Unique ID issued by UMIN | UMIN000015498 |
---|---|
Receipt number | R000018006 |
Scientific Title | Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registry - Warfarin cohort |
Date of disclosure of the study information | 2014/10/22 |
Last modified on | 2016/11/24 16:07:35 |
Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registry - Warfarin cohort
JACRE-W
Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registry - Warfarin cohort
JACRE-W
Japan |
Non-valvular atrial fibrillation patients scheduled to undergo the catheter ablation procedure
Cardiology |
Others
NO
To evaluate effectiveness and safety of practical uses of warfarin in peri-procedural of catheter ablation in patients with non-valvular atrial fibrillation
Safety,Efficacy
Composite of thromboembolic events and major bleedings within 1 month since catheter ablation procedure
- Thromboembolic events; transient ischemic attack, ischemic stroke, non-CNS systemic embolism
- Major bleeding: pericardial effusion requiring a drainage procedure (cardiac tamponade),puncture hematoma requiring surgery, other bleeding episodes requiring blood transfusion, intracranial hemorrhage
- Thromboembolism within 1 month since catheter ablation procedure
- Major bleeding within 1 month since catheter ablation procedure
- Non-major bleeding within 1 month since catheter ablation procedure
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Non-valvular atrial fibrillation patients scheduled to undergo the catheter ablation procedure and to have been receiving warfarin for at least 3 weeks at the time of admission for catheter ablation procedure
- Patients for whom catheter ablation for atrial fibrillation is contraindicated
- Patients with a history of thromboembolism or myocardial infarction within 2 months prior to enrollment
550
1st name | |
Middle name | |
Last name | Ken Okumura |
Hirosaki University Graduate School of Medicine
Department of Cardiology
5, Zaifu-cho, Hirosaki, Aomori, 036-8562 Japan
0172-33-5111
okumura@cc.hirosaki-u.ac.jp
1st name | |
Middle name | |
Last name | Bell Medical Solutions Inc. |
Bell Medical Solutions Inc.
Clinical Research and Development Division
Bunkyo Green Court, 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JAPAN
0120-291-335
jimukyoku@medical-bs24.com
Reimeikyo
Remeikyo
Non profit foundation
NO
2014 | Year | 10 | Month | 22 | Day |
Published
https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-16-0621/_article
The rates of thromboembolism and major bleeding events during the AF ablation perioperative period in Japanese patients treated with rivaroxaban was as low as in those treated with warfarin.
Completed
2014 | Year | 08 | Month | 25 | Day |
2014 | Year | 10 | Month | 24 | Day |
2015 | Year | 10 | Month | 20 | Day |
2015 | Year | 10 | Month | 31 | Day |
2015 | Year | 11 | Month | 30 | Day |
2016 | Year | 01 | Month | 31 | Day |
registered observational study
2014 | Year | 10 | Month | 22 | Day |
2016 | Year | 11 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018006
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |